Literature DB >> 22322995

Lamotrigine in the treatment of unipolar depression with and without comorbidities: a literature review.

Adam Daniel Zavodnick1, Rizwan Ali.   

Abstract

To review the available data behind the use of lamotrigine in unipolar depression and common comorbid conditions. A PubMed based literature review was conducted using keywords related to lamotrigine, depression, anxiety, post traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and personality disorders. A large number of trials using lamotrigine for unipolar depression and various comorbid conditions were reviewed. A major limitation behind the majority of studies was a limited course of the treatment phase. The most robust data was found among studies that followed patients for over 8 weeks, and used higher dosages. Patients with comorbid anxiety states appeared to benefit. Patients with borderline personality disorder also appeared to benefit. The benefits of lamotrigine in unipolar depression have been inconsistently noted in a number of studies. This is due in part to short treatment phases, atypical domains of benefit and different patient populations across studies. Patients with more treatment-resistance, comorbid anxiety and borderline personality disorder may be more able to benefit from lamotrigine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322995     DOI: 10.1007/s11126-012-9208-4

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  33 in total

1.  Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.

Authors:  T C Kumar; S Khanna
Journal:  Aust N Z J Psychiatry       Date:  2000-06       Impact factor: 5.744

Review 2.  Diagnosis and definition of treatment-resistant depression.

Authors:  Maurizio Fava
Journal:  Biol Psychiatry       Date:  2003-04-15       Impact factor: 13.382

3.  Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  MedGenMed       Date:  2006-08-23

4.  Persistent attentional dysfunction in remitted bipolar disorder.

Authors:  K E Wilder-Willis; K W Sax; H L Rosenberg; D E Fleck; P K Shear; S M Strakowski
Journal:  Bipolar Disord       Date:  2001-04       Impact factor: 6.744

5.  Lamotrigine augmentation in unipolar depression.

Authors:  Fabio Lopes Rocha; Claudia Hara
Journal:  Int Clin Psychopharmacol       Date:  2003-03       Impact factor: 1.659

Review 6.  Lamotrigine: a review of its use in bipolar disorder.

Authors:  David R Goldsmith; Antona J Wagstaff; Tim Ibbotson; Caroline M Perry
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder.

Authors:  Donald Bradford Reich; Mary C Zanarini; Katheryn A Bieri
Journal:  Int Clin Psychopharmacol       Date:  2009-09       Impact factor: 1.659

8.  Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study.

Authors:  Frank Schindler; Ion G Anghelescu
Journal:  Int Clin Psychopharmacol       Date:  2007-05       Impact factor: 1.659

9.  Lamotrigine as an augmentation agent in treatment-resistant depression.

Authors:  James G Barbee; Nowal J Jamhour
Journal:  J Clin Psychiatry       Date:  2002-08       Impact factor: 4.384

Review 10.  Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders.

Authors:  Terence A Ketter; Husseini K Manji; Robert M Post
Journal:  J Clin Psychopharmacol       Date:  2003-10       Impact factor: 3.153

View more
  6 in total

1.  Maternal and Fetal Outcomes After Lamotrigine Use in Pregnancy: A Retrospective Analysis from an Urban Maternal Mental Health Centre in New Zealand.

Authors:  Chandni Prakash; Susan Hatters-Friedman; Charmian Moller-Olsen; Abigail North
Journal:  Psychopharmacol Bull       Date:  2016-08-15

2.  Pharmacological Management of Anxiety Disorders in the Elderly.

Authors:  Elizabeth A Crocco; Sindy Jaramillo; Caroline Cruz-Ortiz; Katherine Camfield
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-10

Review 3.  Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.

Authors:  Rebecca L Dean; Tahnee Marquardt; Claudia Hurducas; Styliani Spyridi; Annabelle Barnes; Rebecca Smith; Philip J Cowen; Rupert McShane; Keith Hawton; Gin S Malhi; John Geddes; Andrea Cipriani
Journal:  Cochrane Database Syst Rev       Date:  2021-10-08

Review 4.  Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches.

Authors:  Jeremy D Coplan; Cindy J Aaronson; Venkatesh Panthangi; Younsuk Kim
Journal:  World J Psychiatry       Date:  2015-12-22

5.  Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.

Authors:  Mohammadrasoul Khalkhali; Setareh Aram; Homa Zarrabi; Moosa Kafie; Abtin Heidarzadeh
Journal:  Iran J Psychiatry       Date:  2016-04

6.  Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report.

Authors:  Takeshi Terao; Atsuko Ishida; Toshifumi Kimura; Mitsuhiro Yoshida; Terufumi Hara
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-06       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.